2019
DOI: 10.1093/ecco-jcc/jjy222.515
|View full text |Cite
|
Sign up to set email alerts
|

P391 Are cut-off ranges of Infliximab serum levels in Crohn’s disease always the same in clinical practice?

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles